Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

National Viral Hepatitis Progress Report

Thumbnail of report cover

Progress Toward Viral Hepatitis Elimination in the United States [PDF – 46 pages], is an inaugural report highlighting the nation’s progress toward reducing the burden of hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infections. The report reflects progress toward accomplishing the goals outlined in the 2017-2020 HHS National Viral Hepatitis Action Plan [PDF – 84 pages] and the Division of Viral Hepatitis Strategic Plan, 2016-2020 [PDF – 17 pages] and suggests specific strategies for overcoming existing challenges to eliminating viral hepatitis.  The report also complements a March 2017 report released by the U.S. National Academies of Sciences, Engineering, and Medicine titled A National Strategy for the Elimination of Hepatitis B and C, which highlights the actions necessary to eliminate hepatitis B and hepatitis C as public health threats in the United States by 2030.

Report At-A-Glance

Seven Indicators Used to Measure Progress toward Elimination

Unique to the national progress report is a new set of seven standardized viral hepatitis indicators, each with annual targets and accompanying 2020 goals.

2020
Goal
2015
Target1
2014
Baseline
2015
Baseline
Status
Hepatitis A
 Increase the percentage of children aged 19–35 months who receive ≥2 doses of hepatitis A vaccine  85.0%  62.1%  57.5%  59.6% arrow on yellow, indicating 'Not Met - moved toward annual target'
 Reduce the rate2 of reported HAV infections  0.30  0.38  0.39  0.43 X on red, indicating 'Not met—no change or moved away from annual target'
Hepatitis B
 Increase the percentage of infants who receive hepatitis B vaccine within 3 days of birth  85.0%  74.5%  72.4%  72.4% X on red, indicating 'Not met—no change or moved away from annual target'
 Reduce the rate2 of reported acute HBV infections among persons aged ≥19 years  0.50  1.05  1.16  1.38 X on red, indicating 'Not met—no change or moved away from annual target'
 Reduce the rate2 of HBV-related deaths  0.48  0.50  0.50  0.45 Check on Green, indicating 'Met or exceeded current annual target'
Hepatitis C
 Reduce the rate1 of reported acute HCV infections  0.25  0.66  0.74  0.81 X on red, indicating 'Not met—no change or moved away from annual target'
 Reduce the rate2 of HCV-related deaths  4.17  4.87  5.01  4.91 Arrow on yellow, indicating 'Not Met - moved toward annual target'
Target for 2015 assumes a constant (linear) rate of change from the observed baseline (2014) to the 2020 goal
Per 100,000 U.S. population
Check on Green, indicating 'Met or exceeded current annual target'Met or exceeded current annual target Arrow on yellow, indicating 'Not Met - moved toward annual target' Not met—moved toward annual target in most recent data year X on red, indicating 'Not met—no change or moved away from annual target'Not met—no change or moved away from annual target in most recent data year

The Nation’s Progress toward Reducing the Burden of HAV, HBV, and HCV

 This report demonstrates that much work remains to meet our national targets and ultimately eliminate viral hepatitis as a public health threat in the United States. CDC will continue to monitor the burden of viral hepatitis in the nation, report changes in performance measures and indicators of health outcomes, and share progress in toward achieving our goals.

Learn more about Viral Hepatitis and Elimination

TOP